Delivery Order SPE2DB22D3301-SPE2DB25FY1YA

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,741.00 for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,815.73, is a Firm Fixed Price Delivery Order for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.05, is a Firm Fixed Price Delivery Order for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,460.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Hydromorphone 2 mg/ml Carpujctml, a pharmaceutical product, with a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a $3,889.22 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of HYDROMORPHONE 1 MG/ML VIALML, a pharmaceutical product, with a firm fixed price of $1,195.90 and a completion date of March 7, 2024. The contract is not designated as a set-aside and was awarded as a delivery order under a larger indefinite delivery contract (IDC) with a potential...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,137.70, is for the supply of hydromorphone 1 mg/ml carpujctml. This contract does not have a set-aside designation, indicating it was competitively awarded. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML. The contract is a Firm Fixed Price agreement with a ceiling value of $4,065.00 and an ultimate completion date of August 16, 2024. This award is not set aside for any particular business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,566.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564288240 - Hydromorphone 1 mg/ml Carpujctml, a pharmaceutical product, with a completion date of April 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,053.71 fixed-price contract is for the supply of Hydromorphone 1 mg/ml carpujctml, a prescription medication. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY1YA
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,111.80, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of $999,999,999 and runs through November 2026.

The contract covers the delivery of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product, to support military healthcare programs. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of March 21, 2025.

Generated 6/21/25, 10:05 AM